Stock MVR0 MEDIVIR AB
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Medivir AB Deutsche Boerse AG

Equities

MVR0

SE0020181014

Delayed Deutsche Boerse AG
Other stock markets
 03:57:50 2024-07-17 EDT 		5-day change 1st Jan Change
0.22 EUR -3.51% Intraday chart for Medivir AB -11.65% +0.55%
06-27 Medivir AB Presents Positive New Data from Its Ongoing Phase Ib / IIa Study of Fostroxacitabine Bralpamide + Lenvima® in Advanced Hepatocellular Carcinoma CI
06-20 Certain Shares of Medivir AB are subject to a Lock-Up Agreement Ending on 20-JUN-2024. CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 118B
ARGENX SE Stock argenx SE
 27.87B -
BIONTECH SE Stock BioNTech SE
 20.95B -
GENMAB A/S Stock Genmab A/S
 16.92B
  1. Stock Market
  2. Equities
  3. MVIR B Stock
  4. MVR0 Stock
  5. Charts Medivir AB
  6. Sector Chart